E10.620
Type 1 diabetes mellitus with diabetic dermatitis
Clinical Classification Guidelines
Inclusion Terms
- Type 1 diabetes mellitus with diabetic necrobiosis lipoidica
Medical Intelligence & Overview
Type 1 diabetes mellitus with diabetic dermatitis is a complication of type 1 diabetes characterized by skin conditions linked to high blood sugar levels. Specifically, diabetic dermatitis refers to skin changes associated with diabetes, with necrobiosis lipoidica being a common form. This condition involves skin thinning, discoloration, and ulceration, primarily affecting the lower legs. Recognizing these skin changes can be important in managing overall diabetes health and preventing complications.
Causes & Symptoms
Clinical Causes: Autoimmune destruction of insulin-producing cells in the pancreas leading to insulin deficiency Persistent high blood glucose levels damaging blood vessels and tissues Chronic hyperglycemia weakening the skin's structure and immune response Genetic predisposition influencing skin and immune responses Poorly controlled diabetes increasing the risk of skin complications
Key Symptoms: Chronic skin patches that are yellow, brown, or reddish in color Areas of skin that are shiny, thin, or atrophic Lesions, often on the shins, that may ulcerate or develop open sores Indurated (hardening) skin with a waxy or fibrous appearance Discoloration of skin around the affected area Itching or sensitivity in the affected skin regions (less common)
Diagnostic & Treatment
Diagnosis Path: Diagnosis generally involves a physical examination of skin changes, along with a review of the patient's medical history. Healthcare providers may perform skin biopsies to differentiate diabetic dermatitis from other skin conditions. Blood tests to assess blood sugar levels and diabetes control status are also essential. Imaging or ultrasounds are rarely needed but may be used to evaluate ulceration or underlying tissue involvement.
Treatment Protocols: Tight regulation of blood glucose through insulin therapy and lifestyle modifications Topical treatments such as corticosteroids or emollients to reduce inflammation and moisturize the skin Protective measures to prevent skin trauma and infection Ulcer care if open wounds are present, including appropriate dressings and infection control Addressing any other skin infections or dermatological conditions Regular dermatological assessments to monitor skin health
Clinical Advice & FAQs
Billing Guidance
Is E10.620 a billable ICD-10 code?
Yes, E10.620 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.620?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with diabetic dermatitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference